Literature DB >> 6795758

Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.

A M Lefer, S Okamatsu, E F Smith, J B Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6795758     DOI： 10.1016/0049-3848(81)90016-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  Sequential histamine inhalations cause increased bronchial histamine reactivity in guinea pigs: role of platelets, thromboxanes and prostacyclin.

Authors:  W Dorsch; C Hintschich; J Neuhauser; J Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

2.  Pathophysiological mechanisms of sudden death induced by platelet activating factor.

Authors:  A M Lefer; H F Müller; J B Smith
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

3.  Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.

Authors:  S E Burke; A M Lefer; G M Smith; J B Smith
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.

Authors:  E F Smith; A M Lefer; J B Smith; K C Nicolaou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

5.  Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.

Authors:  M J Parry
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Salutary actions of thromboxane synthetase inhibition during global myocardial ischemia.

Authors:  A M Lefer; M Messenger; S Okamatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.